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Background: α-Mangostin (α-MG) is a main constituent of the fruit hull of the mangosteen. Previous studies have
shown that α-MG has pharmacological activities such as antioxidant, antitumor, anti-inflammatory, antiallergic,
antibacterial, antifungal and antiviral effects. This study aims to investigate the anti-inflammatory molecular action
of α-MG on gene expression profiles.
Methods: U937 and EL4 cells were treated with different concentrations of α-MG in the presence of 0.1 ng/mL
lipopolysaccharide (LPS) for 4 h. The anti-inflammatory effects of α-MG were measured by the levels of tumor
necrosis factor (TNF)-α and interleukin (IL)-4 in cell culture media, which were determined with enzyme-linked
immunosorbent assay kits. The gene expression profiles of all samples were analyzed with a whole human genome
microarray, Illumina BeadChip WG-6 version 3, containing 48804 probes. The protein levels were determined by
Western blotting analyses.
Results: α-MG decreased the LPS induction of the inflammatory cytokines TNF-α (P= 0.038) and IL-4 (P= 0.04).
α-MG decreased the gene expressions in oncostatin M signaling via mitogen-activated protein kinase (MAPK)
pathways, including extracellular signal-regulated kinases (P= 0.016), c-Jun N-terminal kinase (P= 0.01) , and p38
(P= 0.008). α-MG treatment of U937 cells reduced the phosphorylation of MAPK kinase 3 / MAPK kinase 6
(P= 0.0441), MAPK-activated protein kinase-2 (P= 0.0453), signal transducers and activators of transcription-1 (STAT1)
(P= 0.0012), c-Fos (P= 0.04), c-Jun (P= 0.019) and Ets-like molecule 1 (Elk-1) (P= 0.038).
Conclusion: This study demonstrates that α-MG attenuates LPS-mediated activation of MAPK, STAT1, c-Fos, c-Jun
and EIK-1, inhibiting TNF-α and IL-4 production in U937 cells.Background
The mangosteen fruit has been used in Chinese and
Ayurvedic medicine [1]. Extracts of mangosteen have
antioxidant, antitumor, anti-inflammatory, antiallergic,
antibacterial, antifungal and antiviral effects [1-3]. α-
Mangostin (α-MG), which was first isolated from the
mangosteen in 1855, is a competitive antagonist of the
histamine H1 receptor and possesses many biological
properties, such as anti-inflammatory, anti-oxidative
damage and antioxidant activities [4-6]. Previous studies
have shown that α-MG significantly inhibits nitric oxide* Correspondence: ens@itri.org.tw
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reproduction in any medium, provided the or(NO), prostaglandin E2 (PGE2), tumor necrosis factor
(TNF)-α and inducible NOS (iNOS) production in lipo-
polysaccharide (LPS)-stimulated RAW 264.7 cells [3,6,7].
PGE2, TNF-α and iNOS are cytokines involved in inflam-
matory processes, including increased vascular permeabil-
ity, vascular dilation and neutrophil chemotaxis [8,9].
LPS stimulation of human monocytes activates several
intracellular signaling pathways that include the IκB kin-
ase (IKK) and nuclear factor-κB (NF-κB) pathway and
three mitogen-activated protein kinase (MAPK) pathways:
extracellular signal-regulated kinases 1 and 2 (ERK1/2),
c-Jun N-terminal kinase (JNK) and p38 [10]. In turn, these
signaling pathways activate a variety of transcription fac-
tors including NF-κB (p50/p65) and activator protein 1
(AP-1; c-Fos/c-Jun), which coordinate the induction of
many genes encoding inflammatory mediators [10]. How-
ever, the anti-inflammatory molecular effects of the α-MGThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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myeloid leukemic cell line, to different concentrations of
α-MG allows examination of the transcriptional responses
and investigation of the exact intracellular effects of α-MG
using complementary DNA (cDNA) microarrays.
This study aims to investigate the effects of the α-MG
on the expression of three MAPK pathways, ERK1/2,
JNK and p38 in cultured U937 cells.
Methods
Chemicals and reagents
LPS (from Escherichia coli), RPMI 1640 medium, 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2 H-tetrazolium brom-
ide (MTT), phosphate-buffered saline (PBS), antibiotics,
L-glutamine and trypsin-EDTA were purchased from
Gibco BRL (USA). Fetal bovine serum was purchased
from Hyclone Laboratories Inc. (USA). Enzyme-linked im-
munosorbent assay (ELISA) test kits for Human IL-4
DuoSet and Human TNF-α DuoSet were obtained from
R&D Systems (USA). Phospho-p38 MAPK (Thr180/
Tyr182) rabbit monoclonal, phospho-SAPK/JNK (Thr183/
Tyr185) rabbit monoclonal, phospho-ERK1/2 (Thr202/
Tyr204) rabbit monoclonal, phospho- EIK-1 (Ser383)
rabbit monoclonal, phospho-c-Fos (Ser32) rabbit
monoclonal, phospho-c-Jun (Ser63) rabbit monoclonal,
phospho-MMK3/MMK6 (Ser189/207) rabbit monoclonal,
phospho-MAPKAPK-2 (Thr334) rabbit monoclonal,
phospho-STAT1 (Try701) rabbit monoclonal, c-Fos rabbit
monoclonal and c-Jun rabbit monoclonal antibodies were
obtained from Cell Signaling Technology (USA). α-MG
was provided by Dr. Iinuma Munekazu. A Bradford assay
kit was purchased from Bio-Rad (Germany). A mirVana
miRNA Isolation Kit was purchased from Ambion Inc.
(USA). All other chemicals were purchased from Sigma-
Aldrich (USA).
Cell culture
The human myeloid leukemic cell line U937 (ATCC No.
CRL-1593.2) was purchased from the American Type
Culture Collection (USA). The cells were cultured in
RPMI 1640 medium supplemented with 10% (v/v) fetal
bovine serum, 2 mM glutamine, 100 U/mL penicillin
and 100 μg/mL streptomycin at 37°C under 5% CO2.
EL4 cells were purchased from the American Type Cul-
ture Collection (ATCC TIB-39). The cells were cultured
in Dulbecco’s modified Eagle’s medium supplemented
with 10% (v/v) fetal bovine serum, 2 mM glutamine, 100
U/mL penicillin and 100 μg/mL streptomycin at 37°C
under 5% CO2.
Differentiation induction
U937 cells were cultured in RPMI 1640 medium supple-
mented with 10% (v/v) fetal calf serum, 2 mM glutam-
ine, 100 U/mL penicillin and 100 μg/mL streptomycin at37°C under 5% CO2. For differentiation induction, the
cells were seeded at a density of 2 × l07 cells per T150
flask. Differentiation was initiated by addition of phor-
bol-12-myristate-13-acetate to the culture medium to a
final concentration of 50 ng/mL and allowed to proceed
for 24 h. The U937 cells were then washed with complete
culture media once and incubated in U937 culture
medium for 48 h.
TNF-α and IL-4 cytokine assays
Differentiated U937 and EL-4 cells were aliquoted into
the wells of 96-well plates at a density of 1.6 × 105 cells/
well, mixed with different concentrations of α-MG.
U937 cells were treated with 7.6, 12.5, 30.5 nM, respect-
ively. EL-4 cells were treated with 3.0, 6.1, 12.2 nM, re-
spectively and incubated for 30 min at 37°C under 5%
CO2. LPS (0.1 ng/mL) was added to the differentiated
U937 and EL-4 cells and incubated for 4 h. The culture
media were then harvested for TNF-α analyses with
Human TNF-α DuoSet ELISA kit (R&D Systems, USA).
The culture media were harvested for IL-4 analyses with
Human IL-4 DuoSet ELISA kit (R&D Systems, USA).
The half maximal inhibitory concentration (IC50; μg/mL)
was calculated with GraFit software (version 7; GraFit
Data Analysis Software, USA).
Cytotoxicity assay
Cytotoxicity assays were performed by the MTT
method. Cells were incubated with 100 μL of 1 mg/mL
MTT for 1 h at 37°C under 5% CO2. DMSO (100 μL)
was added to dissolve the crystals and the OD560 was
measured with an ELISA reader (Spectrafluor Plus,
Tecan, Switzerland). The results were expressed as cell
viability percentages among LPS-stimulated cells.
Microarray analysis
RNA isolation
U937 cells were harvested into pellets, washed with PBS
and stored at −80°C until extraction. Total RNA and
small RNAs from the cultured cells were isolated using
the mirVana miRNA Isolation Kit.
Gene expression
The gene expression profiles were analyzed using a whole
human genome microarray containing 48,804 probes
(BeadChip WG-6 version 3; Illumina Inc., USA). Biotin-
labeled complementary RNA (cRNA) for hybridization
was generated by in vitro transcription based on the
Eberwine protocol using Illumina Human Whole
Genome-6 expression BeadChip kits (Illumina Inc,
USA). Total RNA (500 ng) was reverse-transcribed into
cDNA, followed by linear amplification steps according
to an Illumina TotalPrep RNA Amplification Kit
(Ambion Inc., USA). Hybridization was performed with
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array. After incubation at 58°C for 16 h, the BeadChip
WG-6 was washed with fresh wash tray according to
Illumina Whohle-Genome Gene Expression Direct
Hybridization Assay, stained with streptavidin-Cy3 dye
(Amersham Biosciences, Buckinghamshire, UK) and
scanned as described in the Illumina manual. The
HumanWG-6 v3.0 Expression BeadChip WG-6 con-
tains six arrays on a single BeadChip WG-6, each with
48,804 probes derived from human genes in the NCBI
RefSeq and UniGene databases. Each array on the
BeadChip WG-6 covers genome-wide transcription of
well-characterized genes, gene candidates and spliceFigure 1 Inhibition of TNF-α and IL-4 secretion from U937 and EL4 ce
presence or absence of different concentrations of α-MG, 7.6, 12.5, 30.5 nM
quantified by ELISA. The TNF-α content (gray bars) and cell viabilities (open
presence or absence of different concentrations of α-MG, 3.0, 6.1, 12.2 nM,
quantified by ELISA. The IL-4 content (gray bars) and cell viabilities (open b
repeated independently three times. *P< 0.05, significant difference from Lvariants. The intensity of each probe was calculated as
the average intensity of at least 15 beads. Array images
and data output were processed using Illumina Bead-
Studio software (Ambion Inc, USA). The analysis meth-
ods for the gene expressions using R and BioConductor
2.10 Software Packages (Biobase, beadarray, limma
packages of R/BioConductor were used).
Gene expression profiling
The gene expression profiles of undifferentiated and dif-
ferentiated U937 cells were determined using the Illu-
mina WG-6 version 3 Beadarray (Illumina Inc., USA).
The raw intensity of spots was log-2 transformed forlls by α-MG. (A) U937 cells were treated with 0.1 ng/mL LPS in the
, respectively for 4 h. TNF-α secreted into the conditioned media was
bars) are shown. (B) EL4 cells were treated with 0.1 ng/mL LPS in the
respectively for 18 h. IL-4 secreted into the conditioned media was
ars) are shown. All experiments were performed in triplicate and
PS treatment.
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formed within all arrays to adjust the systematic vari-
ation of experiments and dye effects. Significantly
changed genes were identified by Limma test with BH
(Benjamini & Hochberg) adjust P values of less than
0.05.Figure 2 Microarray analysis of α-MG in LPS-stimulated U937 cells. (A
(most significant 20 pathways). (B) Groups of genes suppressed or inducedPathway and gene ontology analysis
The pathway and gene ontology analyses were per-
formed using the MetaCore software (GeneGo Inc.,
USA), in which the differentially expressed gene sets for
LPS and α-MG comprised the significantly changed
genes between the two conditions and were annotated) Analysis of α-MG-regulated pathways using the MetaCore database
following exposure to α-MG.
Figure 3 (See legend on next page.)
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Figure 3 α-Mangostin regulates OSM signaling in U937 cells. Four genes (JUNB, JUN, OSM, STAT1) are differential expressed between the
LPS-alpha treated state and LPS-only treated state.
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Western blot analysis
Differentiated U937 cells at a density of 4 × 106 cells/well
were pretreated with 13.4 nM α-MG for 30 min. The U937Figure 4 α-MG decreases LPS-mediated activation of MAPK pathways
0.1 ng/mL LPS for 4 h and then lysed. The cell lysates were subjected to W
anti-phospho-ERK1/2, anti-phospho-JNK, and anti-phospho-p38. β-tubulin w
were normalized by the corresponding β-tubulin expression levels. Data ar
closed bars; 6 nM α-MG, open bars). All experiments were performed in trip
difference from LPS treatment.culture medium contained 0.1 ng/mL LPS, and the incuba-
tion was continued for 4 h at 37°C under 5% CO2. The
cells were washed twice with ice-cold PBS, resuspended in
lysis buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl,
1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM so-
dium pyrophosphate, 1 mM β-glycerophosphate, 1 mMin U937 cells. U937 cells were treated with α-MG in the presence of
estern blotting analyses with ERK1/2, JNK, and p38. Western blots with
as evaluated as a loading control, and the protein expression levels
e expressed as fold phosphorylation normalized to LPS (12 nM α-MG,
licate and repeated independently three times. *P< 0.05, significant
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(Thermo Fisher Scientific Laboratory, USA) at 16,000× g
for 15 min at 4°C. The clarified cell lysates were used for
Western blot analyses. The protein concentrations were
determined using the Bradford assay kit (Ambion Inc.,
USA).
Protein extracts (20 μg) under reduced conditions
were fractionated by 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred to
Hybond nitrocellulose membranes. The membranes were
blocked with 3% non-fat milk in Tris-buffered saline con-
taining 0.1% Tween for 1 h. The activations of p38,Figure 5 α-MG decreases LPS-mediated p38 MAPK activation. U937 ce
and then lysed. The cell lysates were subjected to Western blotting analysi
anti-phospho- ELK-1, anti-phospho- MMK3/MMK6, and anti-phospho- MAPK
expression levels were normalized by the corresponding β-tubulin expressi
LPS (12 nM α-MG, closed bars; 6 nM α-MG, open bars). All experiments we
*P< 0.05, significant difference from LPS treatment.MAPK, JNK, ERK1/2, EIK-1, c-Fos, c-Jun, MAPK kinase 3
/ MAPK kinase 6 (MMK3/MMK6), MAPK-activated pro-
tein kinase-2 (MAPKAPK-2) and signal transducers and
activators of transcription-1 (STAT1) were assessed using
phospho-p38 MAPK (Thr180/Tyr182) rabbit monoclonal,
phospho-SAPK/JNK (Thr183/Tyr185) rabbit monoclonal,
phospho-ERK1/2 (Thr202/Tyr204) rabbit monoclonal,
phospho-EIK-1 (Ser383) rabbit monoclonal, phospho-c-
Fos (Ser32) rabbit monoclonal, phospho-c-Jun (Ser63)
rabbit monoclonal, phospho-MMK3/MMK6 (Ser189/
207) rabbit monoclonal, phospho-MAPKAPK-2 (Thr334)
rabbit monoclonal, phospho-STAT1 (Try701) rabbitlls were treated with α-MG in the presence of 0.1 ng/mL LPS for 4 h
s with ELK-1, MMK3/MMK6, and MAPKAPK-2. Western blots with
APK-2. β-tubulin was evaluated as a loading control, and the protein
on levels. Data are expressed as fold phosphorylation normalized to
re performed in triplicate and repeated independently three times.
Figure 6 (See legend on next page.)
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Figure 6 α-MG regulates STAT 1, c-Jun and c-Fos. U937 cells were treated with α-MG in the presence of 0.1 ng/mL LPS for 4 h and then
lysed. The cell lysates were subjected to Western blotting analyses with STAT 1, c-Jun, c-Fos. Western blots with anti-phospho- STAT 1,
anti-phospho- c-Jun, and anti-phospho- c-Fos. β-tubulin was evaluated as a loading control, and the protein expression levels were normalized
by the corresponding β-tubulin expression levels. Data are expressed as fold phosphorylation normalized to LPS (12 nM α-MG, closed bars; 6 nM
α-MG, open bars). All experiments were performed in triplicate and repeated independently three times. *P< 0.05, significant difference from
LPS treatment.
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monoclonal antibodies according to the manufacturer’s
instructions. The antibody-bound protein bands were
visualized by incubation with a horseradish peroxidase-
conjugated secondary antibody (Sigma-Aldrich, USA), fol-
lowed by detection using the ECL system (Amersham
Pharmacia Biotech, USA). The integrated optical densities
of the bands were quantified using Image J software (NIH,
USA). Each sample was normalized by the β-tubulin con-
tent, as a constitutively expressed protein.
Statistical analysis
All experiments were performed in triplicate and repeated
independently at least three times. Data were presented as
mean± standard deviation (SD) and analyzed by one-way
analysis of variance (ANOVA) using SAS 9.1.3 software
(SAS Institute Inc., USA) followed by a Tukey test to de-
termine any significant differences. P values less than 0.05
were considered statistically significant. Dose dependence
was visually determined from the dose–response graphs.
Results and discussion
Inhibition of LPS-induced TNF-α and IL-4 production
LPS significantly induced the production of TNF-α and IL-
4 in U937 cells. The inhibitory effects of α-MG on inflam-
matory cytokines were evaluated by measuring the amounts
of secreted TNF-α and IL-4 in LPS-stimulated U937 cells
after treatment with α-MG. α-MG inhibited the production
of TNF-α (P=0.038) (Figure 1A) and IL-4 (P=0.04)
(Figure 1B) in a dose-dependent manner. The anti-
inflammatory effects of α-MG could be attributed to the in-
hibition of inflammatory cytokine production or a reduc-
tion in the number of U937 cells through cytotoxicity. The
latter possibility was excluded by comparing the numbers
of cells cultured with the different concentrations of α-MG,
wherein no significant decreases in cell viability were
observed when the concentration was below 15.2 nM
(P=0.1) (Figure 1A). The IC50 of α-MG was 13.4±0.4 nM.
Microarray analysis
Treatment of LPS-stimulated U937 cells with 13.4 nM α-
MG changed the gene expression pattern (Figure 2A).
There were 1536 and 1491 significantly changed genes at
1 and 6 h with LPS and the combination of LPS and α-
MG, respectively. The gene expressions altered after α-
MG treatment were involved in pathways related toinflammation-based immune responses, stress responses,
regulation of apoptosis and regulation of programmed cell
death. Among the approximately 183 genes showing the
strongest suppression, 46 genes were related to immune
responses and inflammatory responses (Figure 2B). These
immune response-related pathways were involved in IL-1
signaling, oncostatin M (OSM) signaling, cytokine pro-
duction, and Th1 and Th2 cell differentiation.
OSM is expressed in autoimmune diseases, including
rheumatoid arthritis, multiple sclerosis and inflammatory
conditions [11]. We observed that α-MG is a promising
agent for autoimmune diseases (unpublished data). The
results from the microarray showed that JUNB, c-Jun,
OSM and STAT1 were differentially expressed between
the LPS and α-MG-cotreated and LPS-treated cells in the
OSM pathway (Figure 3). α-MG may regulate OSM sig-
naling via MAPK pathways and related downstream pro-
teins, including STAT1, c-Jun and c-Fos. The inhibitory
actions on three MAPK pathways, ERK1/2, JNK and p38,
were examined to delineate the effects of α-MG.Decrease in LPS-mediated MAPK activation
LPS treatment induced the phosphorylation of p38,
ERK1/2 and JNK, and α-MG treatment attenuated these
responses in a dose-dependent manner (P= 0.008 for
phospho-p38; P= 0.016 for phospho-ERK1/2; P= 0.01 for
phospho-JNK) (Figure 4). The level of p38 phosphoryl-
ation was significantly decreased compare with ERK1/2
and JNK (Figure 4). α-MG (12 nM) greatly inhibited p38
phosphorylation, and the phosphorylation was reduced
to just 38% of that in LPS-treated cells.
EIK-1, MMK3/MMK6 and MAPKAPK-2 are sub-
strates of p38 [12], and the effects of α-MG on their
phosphorylation were also examined. LPS treatment
induced phosphorylation of EIK-1 and MMK3/MMK6,
and α-MG treatment attenuated these responses in a
concentration-dependent manner (P=0.038 for phospho-
EIK-1; P=0.0441 for phospho-MMK3/MMK6; P=0.0453
for phospho- MAPKAPK-2). EIK-1, MMK3/MMK6 and
MAPKAPK-2 phosphorylation was greatly inhibited by 12
nM α-MG, and the phosphorylation was reduced to just
78–82% of that in LPS-treated cells (Figure 5). These find-
ings suggest that α-MG exhibits anti-inflammatory activity
by inhibiting MAPK phosphorylation, especially in the
p38 pathway including EIK-1, MMK3/MMK6 and MAP-
KAPK-2.
Figure 7 Pathway analysis of α-MG effects on gene expression in U937 cells.
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The results from the microarray showed that JUNB, c-Jun,
OSM and STAT1 were differentially expressed between the
LPS and α-MG-cotreated and LPS-treated cells in the
OSM pathway. The protein levels of STAT1, c-Jun and c-
Fos were determined by Western blotting analyses. Specif-
ically, α-MG pretreatment attenuated LPS-induced phos-
phorylation of c-Jun and c-Fos and downstream targets of
JNK and ERK1/2 (P=0.04 for phospho-c-Fos) (Figure 6).
We demonstrated that α-MG reduced the induction of
STAT1 (P=0.0012), c-Jun and c-Fos in a concentration-
dependent manner.
As shown in Figure 7, we have demonstrated that the
anti-inflammatory effects of α-MG involves the following:
(1) attenuation of LPS-induced production of IL-4 and
TNF-α; (2) attenuation of LPS-induced activation of JNK,
ERK1/2 and p38; (3) reduction of LPS-induced activation
of EIK-1, MMK3/MMK6 and MAPKAPK-2; and (4) at-
tenuation of LPS-mediated suppression of STAT1, c-Jun
and c-Fos expression. Taken together, these new findings
demonstrate that α-MG inhibits LPS-mediated activationof inflammatory AP-1, MAPK and MAPK-related proteins,
including STAT1, c-Jun and c-Fos.
Conclusion
This study has demonstrated that α-MG attenuates LPS
activation of MAPK, STAT1, c-Fos, c-Jun and EIK-1,
thereby inhibiting TNF-α and IL-4 production in U937
cells.
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